What is the Difference Between Enzalutamide (Enzalutamide) and Enzalutamide
Among prostate cancer drugs, patients often encounter " enzalutamide and Enzalutamide ( Enzalutamide): two different ways of writing, and sometimes the trade name "Encotan" is also seen, so many people mistakenly think that they are different drugs. In fact, these names essentially refer to the same innovative drug, it is just a translation habit There are differences in naming methods. Enzalutamide is an international common name. Domestic literature and drug regulatory agencies usually use "enzalutamide" as the standard translation, while "enzalutamide" is another name formed based on spelling in the early days and can still be seen in some medical journals or materials. As for "Enzalutamide", it is a trade name jointly developed by Pfizer and Astellas Pharmaceuticals for commercial promotion in China and some markets.
Regardless of the name, the drug's ingredients, mechanism of action, and clinical application are exactly the same. They are all new-generation androgen receptor inhibitors, which mainly inhibit the proliferation of tumor cells by blocking the androgen receptor signaling pathway. Compared with first-generation anti-androgens, enzalutamide can interfere with the androgen pathway at a deeper level and is still effective in castration-resistant prostate cancer. It is applicable to both metastatic castration-resistant prostate cancer and is gradually being extended to patients with castration-sensitive stages.
Therefore, patients do not need to worry about the difference between "Enza" and "Enza" when choosing medicines.The two refer to the same medicine. The only thing that needs to be paid attention to is to identify the formal channels and the trade name "Acotan" during the drug purchase process to avoid purchasing drugs that are not standardized or from unknown sources due to name confusion. In academic research, clinical guidelines or medical insurance catalogs, it is also recommended to uniformly use "enzalutamide" as the standard translation to ensure the accuracy and consistency of medical information.
Reference materials:https://www.xtandi.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)